1
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V
Condition(s):Xeroderma PigmentosumLast Updated:September 21, 2023Recruiting
Xeroderma Pigmentosum: 14 Clinical Trials, Page 1 of 2
Hide Studies Not Open or Pending
2
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)
Condition(s):Xeroderma PigmentosumLast Updated:June 18, 2023Recruiting
3
Xeroderma Pigmentosum Patient Experiences
Condition(s):Xeroderma PigmentosumLast Updated:May 14, 2010Unknown status
4
Epidemiological Description of the Kaposi’s Disease in France’s Southeast
Condition(s):Kaposi’s DiseaseLast Updated:May 14, 2019Unknown status
5
XPAND Trial: Enhancing XP Photoprotection Activities – New Directions
Condition(s):Xeroderma PigmentosumLast Updated:July 22, 2020Completed
6
Lenalidomide in Kaposi Disease Associated With HIV Infection
Condition(s):HIV Infection Associated Kaposi DiseaseLast Updated:August 1, 2014Terminated
7
Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
Condition(s):Xeroderma Pigmentosum; Basal Cell Carcinoma; Squamous Cell Carcinoma; Melanoma; Skin CancerLast Updated:September 21, 2023Active, not recruiting
8
Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
Condition(s):Cockayne Syndrome; Skin Neoplasms; Xeroderma Pigmentosum; Trichothiodystrophy Syndromes; GenodermatosisLast Updated:September 11, 2023Recruiting
9
Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients
Condition(s):Skin Cancer; Xeroderma Pigmentosum; Basal Cell Nevus SyndromeLast Updated:September 30, 2009Completed
10
T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum
Condition(s):Precancerous ConditionLast Updated:November 6, 2013Unknown status